The Enterprise Value as of November 2024 (TTM) for Bio-Techne Corporation (TECH) is 11.54B

According to Bio-Techne Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 11.54B. This represents a change of -4.47% compared to the average of 12.08B of the last 4 quarters.

Bio-Techne Corporation (TECH) Historical Enterprise Value (quarterly & annually)

How has TECH Enterprise Value performed in the past?

The mean historical Enterprise Value of Bio-Techne Corporation over the last ten years is 9.32B. The current 11.54B Enterprise Value has changed 12.29% with respect to the historical average. Over the past ten years (40 quarters), TECH's Enterprise Value was at its highest in in the December 2021 quarter at 20.48B. The Enterprise Value was at its lowest in in the December 2015 quarter at 3.45B.

Bio-Techne Corporation (TECH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bio-Techne Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Techne Corporation (TECH) Average Enterprise Value

How has TECH Enterprise Value performed in the past?

The current Enterprise Value of Bio-Techne Corporation (TECH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Bio-Techne Corporation (TECH) Enterprise Value vs. Peers

How is TECH’s Enterprise Value compared to its peers?

Bio-Techne Corporation’s Enterprise Value is less than BioMarin Pharmaceutical Inc. (12.17B), greater than Vaxcyte, Inc. (10.01B), greater than Liquidia Corporation (699.70M), greater than Legend Biotech Corporation (7.40B), less than Seagen Inc. (42.84B), less than Alnylam Pharmaceuticals, Inc. (31.79B), greater than Exelixis, Inc. (10.11B), greater than Halozyme Therapeutics, Inc. (7.58B), greater than Replimune Group, Inc. (984.10M), greater than Nuvalent, Inc. (6.38B), greater than Ventyx Biosciences, Inc. (80.09M), greater than Ascendis Pharma A/S (7.61B), less than United Therapeutics Corporation (15.49B), greater than Apellis Pharmaceuticals, Inc. (3.90B), less than BeiGene, Ltd. (19.75B), greater than Akero Therapeutics, Inc. (2.00B), greater than Blueprint Medicines Corporation (6.36B), greater than Travere Therapeutics, Inc. (1.95B),

Build a custom stock screener for Bio-Techne Corporation (TECH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Techne Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Techne Corporation (TECH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Techne Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.